In melanoma, breast, lung, pancreatic, liver, prostate, colon, ovarian, and blood cancers, SIRT6 has contradictory roles as either oncogene or tumor suppresser at different stages of the cancer or in different tumor cell lines. Here, SIRT6 is linked to neoplasm.